MAZUMDAR CLAIRE (Chief Executive Officer) sold 2.7% of their position (10K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $284.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/14/2026ACC: 0001470831-26-000714
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-10K
Net shares
Net seller
$284.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10K
Price / share
$3.79
Trade value
$37.90K
% of position
2.8%
7/10/2026
362.15K→372.15K
Common Stock
Direct
Shares
−9.97K
Price / share
$28.42
Trade value
$283.37K
% of position
2.7%
7/10/2026
372.15K→362.18K
Common Stock
Direct
Shares
−28.00
Price / share
$29.68
Trade value
$831.04
% of position
0.0%
7/10/2026
362.18K→362.15K
Total
Net shares
+0.00
Net value
-$246.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2026 | M · Option Exercise | +10K | $3.79 | $37.90K | 2.8% | 362.15K | 372.15K |
| Common Stock Direct | 7/10/2026 | S · Sale | −9.97K | $28.42 | $283.37K | 2.7% | 372.15K | 362.18K |
| Common Stock Direct | 7/10/2026 | S · Sale | −28.00 | $29.68 | $831.04 | 0.0% | 362.18K | 362.15K |
| Total | +0.00 | -$246.30K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
3.7898
Held after
120.55K
Exercisable
—
7/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 7/10/2026 | M · Option Exercise | −10K | 3.7898 | — | 120.55K |